We serve Chemical Name:1-(3,5-dichloro-2-hydroxyphenyl)propan-1-one CAS:18430-74-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-(3,5-dichloro-2-hydroxyphenyl)propan-1-one
CAS.NO:18430-74-5
Synonyms:3,5-dichloro-2-hydroxypropiophenone;3,5-Dichlor-2-hydroxypropiophenon;3,5-Dichloro-2-hydroxypropiophenon
Molecular Formula:C9H8Cl2O2
Molecular Weight:219.06500
HS Code:2914700090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:309.5ºCat 760 mmHg
Density:1.37 g/cm3
Index of Refraction:
PSA:37.30000
Exact Mass:217.99000
LogP:3.29170
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3,5-dichloro-2-hydroxypropiophenone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3,5-Dichloro-2-hydroxypropiophenon physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3,5-dichloro-2-hydroxypropiophenone Use and application,3,5-dichloro-2-hydroxypropiophenone technical grade,usp/ep/jp grade.
Related News: GlaxoSmithKline (GSK) is at the bottom of the top 20 list with the lowest percentage R&D spend/annual revenue at 12%.�� 1-(3,5-dichloro-2-hydroxyphenyl)propan-1-one manufacturer An analysis of the top 20 global companies by R&D spend for 2018 shows that companies with expensive late-stage pipeline drugs are spending significant proportions of their annual revenue on R&D. 1-(3,5-dichloro-2-hydroxyphenyl)propan-1-one supplier GlaxoSmithKline (GSK) is at the bottom of the top 20 list with the lowest percentage R&D spend/annual revenue at 12%.�� 1-(3,5-dichloro-2-hydroxyphenyl)propan-1-one vendor Zhejiang Huahai Pharmaceutical: It is a leading company in domestic APIs, especially in the field of cardiovascular drugs. 1-(3,5-dichloro-2-hydroxyphenyl)propan-1-one factory Zhejiang Huahai Pharmaceutical: It is a leading company in domestic APIs, especially in the field of cardiovascular drugs.